Literature DB >> 33148996

Is Long-Acting Injectable Cabotegravir Likely to Expand PrEP Coverage Among MSM in the District of Columbia?

Matthew E Levy1,2, Anya Agopian1, Manya Magnus1, Anthony Rawls1, Jenevieve Opoku3, Michael Kharfen3, Alan E Greenberg1, Irene Kuo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33148996      PMCID： PMC7975625          DOI： 10.1097/QAI.0000000000002557

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.771


× No keyword cloud information.
  15 in total

1.  Potential Healthcare Insurance and Provider Barriers to Pre-Exposure Prophylaxis Utilization Among Young Men Who Have Sex with Men.

Authors:  Sarah J Marks; Roland C Merchant; Melissa A Clark; Tao Liu; Joshua G Rosenberger; Jose Bauermeister; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2017-11       Impact factor: 5.078

2.  Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?

Authors:  Steven A John; Thomas H F Whitfield; H Jonathon Rendina; Jeffrey T Parsons; Christian Grov
Journal:  AIDS Behav       Date:  2018-04

3.  Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model.

Authors:  Kevin M Maloney; Adrien Le Guillou; Robert A Driggers; Supriya Sarkar; Emeli J Anderson; Amyn A Malik; Samuel M Jenness
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

4.  Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment.

Authors:  Alex Dubov; Adedotun Ogunbajo; Frederick L Altice; Liana Fraenkel
Journal:  AIDS Care       Date:  2018-12-15

5.  Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System.

Authors:  Kathleen M Gallagher; Patrick S Sullivan; Amy Lansky; Ida M Onorato
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

6.  Surveillance of HIV risk and prevention behaviors of men who have sex with men--a national application of venue-based, time-space sampling.

Authors:  Duncan A MacKellar; Kathleen M Gallagher; Teresa Finlayson; Travis Sanchez; Amy Lansky; Patrick S Sullivan
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

7.  MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication.

Authors:  Katie B Biello; Matthew J Mimiaga; Christopher M Santostefano; David S Novak; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2018-04

8.  Enhancing PrEP Access for Black and Latino Men Who Have Sex With Men.

Authors:  Corina Lelutiu-Weinberger; Sarit A Golub
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

9.  Racial/Ethnic Disparities in HIV Preexposure Prophylaxis Among Men Who Have Sex with Men - 23 Urban Areas, 2017.

Authors:  Dafna Kanny; William L Jeffries; Johanna Chapin-Bardales; Paul Denning; Susan Cha; Teresa Finlayson; Cyprian Wejnert
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-09-20       Impact factor: 17.586

10.  National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.

Authors:  Patrick S Sullivan; Travis H Sanchez; Maria Zlotorzynska; Cristian J Chandler; R C Sineath; Erin Kahle; Stephen Tregear
Journal:  J Int AIDS Soc       Date:  2020-03       Impact factor: 5.396
View more
  1 in total

1.  Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake Among Men Who have Sex with Men Who Use Stimulants: A Qualitative Study.

Authors:  Adam Viera; Jacob J van den Berg; Collette D Sosnowy; Nikita A Mehta; E Jennifer Edelman; Trace Kershaw; Philip A Chan
Journal:  AIDS Behav       Date:  2022-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.